NorthX Biologics
Janet Hoogstraate is the Chief Executive Officer at NorthX Biologics, where she also serves as the Site Manager and Board Member. She is also a Board Member at AlzeCure Pharma and Mireca Medicines GmbH. Additionally, she is an Advisory Board Member at the Dutch Chamber of Commerce in Sweden. Janet has a background in chemistry and bio-pharmaceutical sciences, with a Master of Business Administration from Hult International Business School. Her experience includes leadership roles at Valneva, AstraZeneca R&D, and Acturum Life Science AB. Janet has also served in various advisory and board positions in the pharmaceutical and life science industry.